Advances in the treatment of small vessel vasculitis

被引：24
作者：
Molloy, ES
Langford, CA
机构：
[1] Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Ctr Vasculittis Care & Res, Cleveland, OH 44195 USA
[2] Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2006年 / 32卷 / 01期
关键词：
D O I：
10.1016/j.rdc.2005.12.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The systemic small vessel vasculitides encompass Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. The traditional approach to therapy, which incorporates cytotoxic drugs and glucocorticoids, is associated with a significant risk of relapse and treatment-related toxicity. The formation of multicenter collaborative groups has facilitated the execution of randomized controlled trials, and has led to the identification of several effective therapeutic options. This article reviews the existing data and refers to studies in progress that may answer some of the questions that remain regarding the treatment of the systemic small vessel vasculitides.
引用
收藏
页码：157 / +
页数：17
相关论文
共 92 条
[31]   SULFAMETHOXAZOLE-TRIMETHOPRIM THERAPY FOR WEGENERS GRANULOMATOSIS [J].
ISRAEL, HL .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (10) :2293-2295
[32]   A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies [J].
Jayne, D ;
Rasmussen, N ;
Andrassy, K ;
Bacon, P ;
Tervaert, JWC ;
Dadoniene, J ;
Ekstrand, A ;
Gaskin, G ;
Gregorini, G ;
de Groot, K ;
Gross, W ;
Hagen, EC ;
Mirapeix, E ;
Pettersson, E ;
Siegert, C ;
Sinico, A ;
Tesar, V ;
Westman, K ;
Pusey, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :36-44
[33]   Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity [J].
Jayne, DRW ;
Chapel, H ;
Adu, D ;
Misbah, S ;
O'Donoghue, D ;
Scott, D ;
Lockwood, CM .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (07) :433-439
[34]   NOMENCLATURE OF SYSTEMIC VASCULITIDES - PROPOSAL OF AN INTERNATIONAL CONSENSUS CONFERENCE [J].
JENNETTE, JC ;
FALK, RJ ;
ANDRASSY, K ;
BACON, PA ;
CHURG, J ;
GROSS, WL ;
HAGEN, EC ;
HOFFMAN, GS ;
HUNDER, GG ;
KALLENBERG, CGM ;
MCCLUSKEY, RT ;
SINICO, RA ;
REES, AJ ;
VANES, LA ;
WALDHERR, R ;
WIIK, A .
ARTHRITIS AND RHEUMATISM, 1994, 37 (02) :187-192
[35]   Tumour necrosis factor-α (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis [J].
Jónasdóttir, O ;
Petersen, J ;
Bendtzen, K .
APMIS, 2001, 109 (11) :781-786
[36]  
Kallenberg Cees G. M., 2002, Autoimmunity Reviews, V1, P61, DOI 10.1016/S1568-9972(01)00008-8
[37]   Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis [J].
Keogh, KA ;
Wylam, ME ;
Stone, JH ;
Specks, U .
ARTHRITIS AND RHEUMATISM, 2005, 52 (01) :262-268
[38]   THE INDUCING ROLE OF TUMOR NECROSIS FACTOR IN THE DEVELOPMENT OF BACTERICIDAL GRANULOMAS DURING BCG INFECTION [J].
KINDLER, V ;
SAPPINO, AP ;
GRAU, GE ;
PIGUET, PF ;
VASSALLI, P .
CELL, 1989, 56 (05) :731-740
[39]   Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis [J].
Klemmer, PJ ;
Chalermskulrat, W ;
Reif, MS ;
Hogan, SL ;
Henke, DC ;
Falk, RJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1149-1153
[40]   Effectiveness of TNF-α blockade with infliximab in refractory Wegener's granulomatosis [J].
Lamprecht, P ;
Voswinkel, J ;
Lilienthal, T ;
Nolle, B ;
Heller, M ;
Gross, WL ;
Gause, A .
RHEUMATOLOGY, 2002, 41 (11) :1303-1307
12345678910